BBIO icon

BridgeBio Pharma
BBIO

Overview Fund Activity

247 hedge funds and large institutions have $6.76B invested in BridgeBio Pharma in 2023 Q4 according to their latest regulatory filings, with 53 funds opening new positions, 89 increasing their positions, 77 reducing their positions, and 26 closing their positions.

Holders
247
Holders Change
+26
Holders Change %
+11.76%
% of All Funds
3.62%
Holding in Top 10
15
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+50%
% of All Funds
0.22%
New
53
Increased
89
Reduced
77
Closed
26
Calls
$110M
Puts
$90.1M
Net Calls
+$20.2M
Net Calls Change
-$12.9M

Top Buyers

1
Lord, Abbett & Co
1
Lord, Abbett & Co
New Jersey
$125M
2
Morgan Stanley
2
Morgan Stanley
New York
$134M
3
Goldman Sachs
3
Goldman Sachs
New York
$132M
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$517M
5
BlackRock
5
BlackRock
New York
$410M

Top Sellers

1
HA
1
HHLR Advisors
Cayman Islands
$56.2M
2
CAM
2
Cormorant Asset Management
Massachusetts
$135M
3
WP
3
Woodline Partners
California
$11.7M
4
CS
4
Credit Suisse
Switzerland
$3.67M
5
D.E. Shaw & Co
5
D.E. Shaw & Co
New York
$37.3M
Name Market Value Shares Shares
Change 		Shares
Change %
Janus Henderson Group
26
Janus Henderson Group
United Kingdom
$46.2M 1,143,563 -50 -0%
Charles Schwab
27
Charles Schwab
California
$45.3M 1,123,220 +66,945 +6%
Voloridge Investment Management
28
Voloridge Investment Management
Florida
$44.6M 1,105,989 -143,669 -11%
Capital Research Global Investors
29
Capital Research Global Investors
California
$44.4M 1,100,110 – –
UBS Group
30
UBS Group
Switzerland
$39.8M 985,510 +832,940 +546%
Two Sigma Investments
31
Two Sigma Investments
New York
$39M 966,797 -310,287 -24%
Primecap Management
32
Primecap Management
California
$38.1M 944,000 +5,300 +0.6%
Principal Financial Group
33
Principal Financial Group
Iowa
$38.1M 943,484 +197,818 +27%
D.E. Shaw & Co
34
D.E. Shaw & Co
New York
$37.3M 924,865 -416,378 -31%
ACP
35
Altitude Crest Partners
Connecticut
$30.5M 754,560 +754,560 New
Ensign Peak Advisors
36
Ensign Peak Advisors
Utah
$30.1M 745,071 +112,361 +18%
Manulife (Manufacturers Life Insurance)
37
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$30M 744,132 +78,528 +12%
Barclays
38
Barclays
United Kingdom
$30M 742,038 +260,598 +54%
EAM
39
Eventide Asset Management
Massachusetts
$28.9M 716,927 – –
OCA
40
Octagon Capital Advisors
New York
$28.5M 706,800 -264,839 -27%
EA
41
Emerald Advisers
Pennsylvania
$27.7M 685,539 -8,461 -1%
Citadel Advisors
42
Citadel Advisors
Florida
$26.8M 664,155 +95,495 +17%
UBS AM
43
UBS AM
Illinois
$26.7M 660,218 -35,415 -5%
T. Rowe Price Associates
44
T. Rowe Price Associates
Maryland
$26.6M 658,362 +596,386 +962%
Bank of New York Mellon
45
Bank of New York Mellon
New York
$22M 544,019 +80,242 +17%
EMFAT
46
Emerald Mutual Fund Advisers Trust
Pennsylvania
$20.2M 500,254 – –
IC
47
Ikarian Capital
Texas
$19.1M 473,126 – –
American Century Companies
48
American Century Companies
Missouri
$19M 471,866 +163,574 +53%
Victory Capital Management
49
Victory Capital Management
Texas
$18.6M 459,569 +24,156 +6%
Federated Hermes
50
Federated Hermes
Pennsylvania
$18.1M 447,171 -18,605 -4%
1
2
3 4 5